SCHEMBL7208033

SCHEMBL7208033

c1ccc(SCCSCCSCCSc2ccccn2)nc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
KMT2A Q03164 4/20 0.54
MAPT P10636 2/20 0.54
EHMT2 Q96KQ7 1/20 0.54
EHMT1 Q9H9B1 1/20 0.54
APOBEC3G Q9HC16 1/20 0.54
NPC1 O15118 6/20 0.50
RAB9A P51151 6/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
MEN1 O00255 3/20 0.46
PKM P14618 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
HPGD P15428 3/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28474476 0.91 ALDH1A1 (0.51) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL3182706 0.81 ALDH1A1 (0.62) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL5185156 0.81 ALDH1A1 (0.58) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL317308 0.81 ALDH1A1 (0.58) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL4686394 0.81 ALDH1A1 (0.62) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL5020551 0.81 ALDH1A1 (0.58) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL4686390 0.81 ALDH1A1 (0.62) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL10976989 0.81 ALDH1A1 (0.58) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL2077935 0.81 ALDH1A1 (0.58) ALDH1A1KMT2AMAPTEHMT2EHMT1
SCHEMBL7205329 0.79 EHMT2 (0.61) ALDH1A1KMT2AMAPTEHMT2EHMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559852-B2 Composition for tin-silver alloy electroplating comprising a complexing agent BASF SE (DE) 2026-02-24 US disclosed
EP-3775325-B1 COMPOSITION FOR TIN-SILVER ALLOY ELECTROPLATING COMPRISING A COMPLEXING AGENT BASF SE (DE) 2024-08-28 EP disclosed
US-12054842-B2 Composition for tin-silver alloy electroplating comprising a complexing agent BASF SE (DE) 2024-08-06 US disclosed
US-11939691-B2 Tin or tin alloy electroplating bath, and electronic component having electrodeposit formed thereon using the plating bath ISHIHARA CHEMICAL CO., LTD. (JP) 2024-03-26 US disclosed
US-20240060201-A1 COMPOSITION FOR TIN-SILVER ALLOY ELECTROPLATING COMPRISING A COMPLEXING AGENT BASF SE (DE) 2024-02-22 US disclosed
CN-111918985-B Composition for tin-silver alloy electroplating comprising complexing agent 巴斯夫欧洲公司 2024-02-02 CN disclosed
EP-4031695-A1 COMPOSITION FOR TIN-SILVER ALLOY ELECTROPLATING COMPRISING A COMPLEXING AGENT BASF SE (DE) 2022-07-27 EP disclosed
CN-114402096-A Composition for tin-silver alloy electroplating comprising complexing agent 巴斯夫欧洲公司 2022-04-26 CN disclosed
WO-2021052817-A1 COMPOSITION FOR TIN-SILVER ALLOY ELECTROPLATING COMPRISING A COMPLEXING AGENT BASF SE (DE) 2021-03-25 WO disclosed
US-20210025070-A1 COMPOSITION FOR TIN-SILVER ALLOY ELECTROPLATING COMPRISING A COMPLEXING AGENT BASF SE (DE) 2021-01-28 US disclosed
US-6607653-B1 Tin-copper alloy plating bath, tin-copper-bismuth alloy plating bath or tin-copper-silver alloy plating bath containing a soluble metal compound and a specific sulfur-containing compound. The plating bath of the alloy with DAIWA FINE CHEMICALS CO., LTD. (JP) 2003-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559852-B2 Composition for tin-silver alloy electroplating comprising a complexing agent SLC13A3, GNA11, AP3D1 ALDH1A1 3242/4885KMT2A 3462/4885MAPT 3573/4885
US-20240060201-A1 COMPOSITION FOR TIN-SILVER ALLOY ELECTROPLATING COMPRISING A COMPLEXING AGENT SLC39A11, SCN11A, S100A11 ALDH1A1 3902/4885KMT2A 2376/4885MAPT 3343/4885
US-12054842-B2 Composition for tin-silver alloy electroplating comprising a complexing agent SCN11A, GRIA3, NR3C1 ALDH1A1 4520/4885KMT2A 2657/4885MAPT 3409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.